Olema Oncology
Develop therapies to improve outcomes for women living with cancer51-200 EmployeesActively Hiring
Olema Oncology Funding
$250M
11 round
Olema Oncology is active in the following markets / industries: pharmaceuticals, Drug development and Drug discovery. The company has secured funding across 1 rounds, totaling in an amount of $250M. Their most recent funding was raised on December 2, 2024.
Funding Rounds
S
$250000000Investors of Olema Oncology
David Price
Knowledge in content strategy, curation, taxonomies, search quality, and online news. Worked at Pinterest, LinkedIn, Glassdoor, Yahoo!, iCurrent, and Trove.
Cyrus Harmon
CEO/Co-founder @Olema Oncology; PhD in Genetics, UC Berkeley; CEO/Co-founder @Neomorphic -- acquired by @Affymetrix. Advisor: @IDbyDNA. Lisp Hacker.